For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) closed at $61.48 in the last session, down -0.79% from day before closing price of $61.97. In other words, the price has decreased by -$0.79 from its previous closing price. On the day, 0.62 million shares were traded. RYTM stock price reached its highest trading level at $62.645 during the session, while it also had its lowest trading level at $60.71.
Ratios:
We take a closer look at RYTM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.13 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 13.60 whereas as Long-Term Debt/Eq ratio is at 13.50.
On January 02, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $80.Jefferies initiated its Buy rating on January 02, 2025, with a $80 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 10 ’25 when German Christopher Paul sold 2,069 shares for $67.19 per share. The transaction valued at 139,016 led to the insider holds 1,889 shares of the business.
Cramer Pamela J. sold 7,031 shares of RYTM for $478,435 on Jun 06 ’25. The Chief Human Resources Officer now owns 19,209 shares after completing the transaction at $68.05 per share. On Jun 10 ’25, another insider, CHRISTOPHER PAUL GERMAN, who serves as the Officer of the company, bought 2,069 shares for $66.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RYTM now has a Market Capitalization of 3911449856 and an Enterprise Value of 3854689024. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.58 while its Price-to-Book (P/B) ratio in mrq is 206.03. Its current Enterprise Value per Revenue stands at 28.165 whereas that against EBITDA is -14.63.
Stock Price History:
The Beta on a monthly basis for RYTM is 2.30, which has changed by 0.5113077 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, RYTM has reached a high of $69.89, while it has fallen to a 52-week low of $39.46. The 50-Day Moving Average of the stock is -1.00%, while the 200-Day Moving Average is calculated to be 8.99%.
Shares Statistics:
According to the various share statistics, RYTM traded on average about 715.60K shares per day over the past 3-months and 567280 shares per day over the past 10 days. A total of 63.49M shares are outstanding, with a floating share count of 58.23M. Insiders hold about 8.48% of the company’s shares, while institutions hold 95.60% stake in the company. Shares short for RYTM as of 1748563200 were 4775505 with a Short Ratio of 6.67, compared to 1745971200 on 4852888. Therefore, it implies a Short% of Shares Outstanding of 4775505 and a Short% of Float of 9.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
